Yael Kenen
Net worth: - $ as of 30/05/2026
Net worth: - $ as of 30/05/2026
Yael Kenen is currently the Vice President-Clinical Affairs at Epitomee Medical Ltd. Prior to this, Yael worked as the Chief Executive Officer at Lacrima Medical Ltd. and as the Chief Operating Officer at TransPharma Medical Ltd. Yael holds an MBA from Technion-Israel Institute of Technology and a doctorate from The Hebrew University of Jerusalem.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EPITOMEE MEDICAL LTD -.--% | 11/05/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
| Companies | Position | Start |
|---|---|---|
| EPITOMEE MEDICAL LTD | Chief Tech/Sci/R&D Officer | 31/12/2019 |
| Companies | Position | End |
|---|---|---|
Lacrima Medical Ltd.
Lacrima Medical Ltd. Medical SpecialtiesHealth Technology Develops medical treatment device for dry eye disease | Chief Executive Officer | - |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Chief Operating Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Technion-Israel Institute of Technology
Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransPharma Medical Ltd.
TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Provides development and commercialization of drugs | Health Technology |
Epitomee Medical Ltd.
Epitomee Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures medical devices for obesity | Health Technology |
Lacrima Medical Ltd.
Lacrima Medical Ltd. Medical SpecialtiesHealth Technology Develops medical treatment device for dry eye disease | Health Technology |
Select your edition
All financial news and data tailored to specific country editions